| Disease | colorectal neoplasms |
| Phenotype | C0025202|melanoma |
| Sentences | 1 |
| PubMedID- 24076266 | Antitumor activity by gsis and mabs administered as single agent in early phases of clinical trials has been observed in advanced or metastatic thyroid cancer, non-small cell lung cancer, intracranial tumors, sarcoma or desmoid tumors, colorectal cancer with neuroendocrine features, melanoma and ovarian cancer. |
Page: 1